Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Gepotidacin in Renal Impairment
NCT02729038Phase 1Completed
- Sponsor
- GSK
- Start
- Jun 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of gepotidacin in bacterial infection (6 arms), sponsored by GSK. Primary endpoints: Area Under the Plasma Concentration Time Curve From Hour 0 to Infinity, Maximum Observed Plasma Concentration and 5 more. Started Jun 2016; status: completed.
02
Drugs
gepotidacin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT02729038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02729038.